Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Hoxa5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of HOXA5 mRNA | CTD | PMID:22206623 | Hoxa5 | Rat | 17beta-estradiol | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Estradiol results in increased expression of HOXA5 mRNA | CTD | PMID:21632981 | Hoxa5 | Rat | 17beta-estradiol | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of HOXA5 mRNA | CTD | PMID:31614463 | Hoxa5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HOXA5 mRNA | CTD | PMID:15328365 | Hoxa5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HOXA5 mRNA | CTD | PMID:21570461|PMID:24058054 | Hoxa5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HOXA5 mRNA | CTD | PMID:19897914 | Hoxa5 | Rat | 2-butoxyethanol | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of HOXA5 mRNA | CTD | PMID:19812364 | Hoxa5 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of HOXA5 mRNA | CTD | PMID:30851411 | Hoxa5 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of HOXA5 mRNA | CTD | PMID:25912373 | Hoxa5 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of HOXA5 mRNA | CTD | PMID:30951980 | Hoxa5 | Rat | 5-aza-2'-deoxycytidine | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [Decitabine co-treated with trichostatin A] results in increased expression of HOXA5 mRNA | CTD | PMID:17891453 | Hoxa5 | Rat | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of HOXA5 mRNA | CTD | PMID:20488242 | Hoxa5 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA5 mRNA | CTD | PMID:36189433 | Hoxa5 | Rat | all-trans-retinoic acid | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of HOXA5 mRNA | CTD | PMID:21934132 | Hoxa5 | Rat | all-trans-retinoic acid | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Tretinoin results in increased expression of HOXA5; Tretinoin results in increased expression of HOXA5 mRNA | CTD | PMID:16604517|PMID:16788091|PMID:17198874|PMID:36189433|PMID:8838863 | Hoxa5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of HOXA5 mRNA | CTD | PMID:16483693 | Hoxa5 | Rat | antirheumatic drug | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of HOXA5 mRNA | CTD | PMID:24449571 | Hoxa5 | Rat | arotinoid acid | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... | CTD | PMID:34480604 | Hoxa5 | Rat | arsane | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Hoxa5 | Rat | arsenic atom | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Hoxa5 | Rat | arsenous acid | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of HOXA5 mRNA | CTD | PMID:21461292 | Hoxa5 | Rat | benzo[a]pyrene | decreases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of HOXA5 mRNA | CTD | PMID:21569818 | Hoxa5 | Rat | benzo[a]pyrene | affects methylation | ISO | HOXA5 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of HOXA5 promoter | CTD | PMID:27901495 | Hoxa5 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of HOXA5 mRNA | CTD | PMID:15674843 | Hoxa5 | Rat | bisphenol A | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of HOXA5 mRNA | CTD | PMID:30951980 | Hoxa5 | Rat | bisphenol A | decreases methylation | ISO | HOXA5 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of HOXA5 gene | CTD | PMID:31601247 | Hoxa5 | Rat | bisphenol A | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of HOXA5 mRNA | CTD | PMID:29275510 | Hoxa5 | Rat | bisphenol F | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of HOXA5 mRNA | CTD | PMID:30951980 | Hoxa5 | Rat | cadmium dichloride | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of HOXA5 mRNA | CTD | PMID:38568856 | Hoxa5 | Rat | calcitriol | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of HOXA5 mRNA | CTD | PMID:21592394 | Hoxa5 | Rat | calcitriol | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of HOXA5 mRNA | CTD | PMID:21592394 | Hoxa5 | Rat | CHIR 99021 | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... | CTD | PMID:34480604 | Hoxa5 | Rat | chlorpyrifos | decreases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of HOXA5 mRNA | CTD | PMID:37019170 | Hoxa5 | Rat | cisplatin | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of HOXA5 mRNA | CTD | PMID:27392435 | Hoxa5 | Rat | clobetasol | decreases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Clobetasol results in decreased expression of HOXA5 mRNA | CTD | PMID:27462272 | Hoxa5 | Rat | copper(II) chloride | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of HOXA5 mRNA | CTD | PMID:38568856 | Hoxa5 | Rat | cortisol | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... | CTD | PMID:34480604 | Hoxa5 | Rat | cyclosporin A | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of HOXA5 mRNA | CTD | PMID:25562108 | Hoxa5 | Rat | cytarabine | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Cytarabine results in increased expression of HOXA5 mRNA | CTD | PMID:21198554 | Hoxa5 | Rat | diarsenic trioxide | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of HOXA5 mRNA | CTD | PMID:21461292 | Hoxa5 | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of HOXA5 mRNA | CTD | PMID:21658437 | Hoxa5 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of HOXA5 mRNA | CTD | PMID:21551480 | Hoxa5 | Rat | etoposide | affects response to substance | ISO | HOXA5 (Homo sapiens) | 6480464 | HOXA5 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 | Hoxa5 | Rat | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of HOXA5 mRNA | CTD | PMID:18035473 | Hoxa5 | Rat | folic acid | decreases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of HOXA5 mRNA | CTD | PMID:25629700 | Hoxa5 | Rat | genistein | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Genistein results in increased expression of HOXA5 mRNA | CTD | PMID:32186404 | Hoxa5 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of HOXA5 mRNA | CTD | PMID:33387578 | Hoxa5 | Rat | geraniol | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | geraniol results in increased expression of HOXA5 mRNA | CTD | PMID:27683099 | Hoxa5 | Rat | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of HOXA5 mRNA | CTD | PMID:16415329 | Hoxa5 | Rat | manganese atom | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Hoxa5 | Rat | manganese(0) | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Hoxa5 | Rat | manganese(II) chloride | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Hoxa5 | Rat | mitoxantrone | affects response to substance | ISO | HOXA5 (Homo sapiens) | 6480464 | HOXA5 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 | Hoxa5 | Rat | mono(2-ethylhexyl) phthalate | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of HOXA5 mRNA | CTD | PMID:36695872 | Hoxa5 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA5 mRNA | CTD | PMID:36189433 | Hoxa5 | Rat | N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of HOXA5 mRNA | CTD | PMID:16415329 | Hoxa5 | Rat | nickel atom | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Nickel results in decreased expression of HOXA5 mRNA | CTD | PMID:24768652|PMID:25583101 | Hoxa5 | Rat | nitrofen | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | nitrofen results in increased expression of HOXA5 mRNA | CTD | PMID:18351244 | Hoxa5 | Rat | nitrogen dioxide | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of more ... | CTD | PMID:38573328 | Hoxa5 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of HOXA5 mRNA | CTD | PMID:25729387 | Hoxa5 | Rat | ozone | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of HOXA5 more ... | CTD | PMID:34911549 | Hoxa5 | Rat | paracetamol | affects expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of HOXA5 mRNA | CTD | PMID:17562736 | Hoxa5 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of HOXA5 mRNA | CTD | PMID:33387578 | Hoxa5 | Rat | perfluorodecanoic acid | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [perfluorodecanoic acid results in increased expression of HOXA5 mRNA] | CTD | PMID:32534105 | Hoxa5 | Rat | perfluorodecanoic acid | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | perfluorodecanoic acid results in increased expression of HOXA5 mRNA | CTD | PMID:32534105 | Hoxa5 | Rat | perfluorononanoic acid | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of HOXA5 mRNA] | CTD | PMID:32534105 | Hoxa5 | Rat | perfluorononanoic acid | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of HOXA5 mRNA | CTD | PMID:32534105 | Hoxa5 | Rat | perfluorooctanoic acid | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of HOXA5 mRNA | CTD | PMID:32534105 | Hoxa5 | Rat | perfluorooctanoic acid | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of HOXA5 mRNA] | CTD | PMID:32534105 | Hoxa5 | Rat | phosgene | affects expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Phosgene affects the expression of HOXA5 mRNA | CTD | PMID:16300373 | Hoxa5 | Rat | pirinixic acid | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Hoxa5 | Rat | quercetin | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of HOXA5 mRNA | CTD | PMID:21632981 | Hoxa5 | Rat | rac-lactic acid | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of HOXA5 mRNA | CTD | PMID:30851411 | Hoxa5 | Rat | ranitidine | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of HOXA5 mRNA | CTD | PMID:16415329 | Hoxa5 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine results in decreased expression of HOXA5 mRNA | CTD | PMID:33725128 | Hoxa5 | Rat | SB 431542 | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in more ... | CTD | PMID:34480604 | Hoxa5 | Rat | silicon dioxide | increases methylation | ISO | HOXA5 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased methylation of HOXA5 promoter | CTD | PMID:34973136 | Hoxa5 | Rat | sodium arsenite | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of HOXA5 mRNA | CTD | PMID:12760830 | Hoxa5 | Rat | sodium arsenite | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Hoxa5 | Rat | sodium arsenite | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of HOXA5 mRNA | CTD | PMID:38568856 | Hoxa5 | Rat | stigmasterol | multiple interactions | ISO | Hoxa5 (Mus musculus) | 6480464 | [NR1H4 gene mutant form affects the susceptibility to Stigmasterol] which results in decreased expression of more ... | CTD | PMID:30245210 | Hoxa5 | Rat | temozolomide | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of HOXA5 mRNA | CTD | PMID:31758290 | Hoxa5 | Rat | testosterone | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of HOXA5 mRNA | CTD | PMID:21592394 | Hoxa5 | Rat | testosterone | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of HOXA5 mRNA | CTD | PMID:21592394 | Hoxa5 | Rat | thiram | decreases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Thiram results in decreased expression of HOXA5 mRNA | CTD | PMID:38568856 | Hoxa5 | Rat | titanium dioxide | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of HOXA5 mRNA | CTD | PMID:23131501 | Hoxa5 | Rat | titanium dioxide | decreases methylation | ISO | Hoxa5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of HOXA5 gene | CTD | PMID:35295148 | Hoxa5 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of HOXA5 mRNA | CTD | PMID:25729387 | Hoxa5 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of HOXA5 mRNA | CTD | PMID:33387578 | Hoxa5 | Rat | trichostatin A | multiple interactions | ISO | HOXA5 (Homo sapiens) | 6480464 | [decitabine co-treated with trichostatin A] results in increased expression of HOXA5 mRNA | CTD | PMID:17891453 | Hoxa5 | Rat | urethane | increases expression | ISO | HOXA5 (Homo sapiens) | 6480464 | Urethane results in increased expression of HOXA5 mRNA | CTD | PMID:28818685 | Hoxa5 | Rat | valproic acid | decreases methylation | ISO | HOXA5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of HOXA5 gene | CTD | PMID:29154799 | Hoxa5 | Rat | valproic acid | increases expression | ISO | Hoxa5 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of HOXA5 mRNA | CTD | PMID:24896083 | Hoxa5 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of HOXA5 mRNA | CTD | PMID:15686871 | Hoxa5 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of HOXA5 mRNA | CTD | PMID:19015723 | | |||||||||||||||||||||||||||||||||||||||






















